Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C

OBJECTIVE: Although direct-acting antiviral agents (DAAs) have markedly improved the outcome of treatment in chronic HCV infection, there continues to be an unmet medical need for improved therapies in difficult-to-treat patients as well as liver graft infection. Viral entry is a promising target fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gut
Main Authors: Xiao, Fei, Fofana, Isabel, Thumann, Christine, Mailly, Laurent, Alles, Roxane, Robinet, Eric, Meyer, Nicolas, Schaeffer, Mickaël, Habersetzer, François, Doffoël, Michel, Leyssen, Pieter, Neyts, Johan, Zeisel, Mirjam B, Baumert, Thomas F
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2015
Assuntos:
Hepatology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4345833/
https://ncbi.nlm.nih.gov/pubmed/24848265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2013-306155
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados